0001209191-22-028906.txt : 20220513
0001209191-22-028906.hdr.sgml : 20220513
20220513170417
ACCESSION NUMBER: 0001209191-22-028906
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220512
FILED AS OF DATE: 20220513
DATE AS OF CHANGE: 20220513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COOPER GRAHAM K
CENTRAL INDEX KEY: 0001396943
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 22923831
MAIL ADDRESS:
STREET 1: C/O RECEPTOS, INC.
STREET 2: 10835 ROAD TO THE CURE, SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-12
0
0001645666
Kezar Life Sciences, Inc.
KZR
0001396943
COOPER GRAHAM K
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
5.52
2022-05-12
4
A
0
26000
0.00
A
2032-05-11
Common Stock
26000
26000
D
One thirty-sixth (1/36th) of the shares shall vest on a monthly basis commencing on May 12, 2022, subject to the Reporting Person continuing to provide service through each such date.
/s/ Marc Belsky, Attorney-in-Fact
2022-05-13